Explore Our Thought Leadership in Quantitative Medicine
At Quantivis, we believe in advancing the science and practice of model-informed drug development and quantitative medicine.
Our founder, Sandra A.G. Visser, PhD, is an internationally recognized thought leader with numerous publications shaping best practices in clinical pharmacology, translational science, and quantitative medicine strategy. She is the 2025/2026 President of the American Society of Clinical Pharmacology and Therapeutics.
For a complete list of 70+ publications, visit: Sandra Visser (0009-0008-2186-7195) - ORCID
Selected publication highlights, organized by topic, are provided below with a link Pubmed.
Why This Matters for Your Program
These scientific contributions show how PKPD concepts, quantitative strategies translate into real value for patients. Together, these publications underscore the core principles behind Quantivis’ consulting approach: anchoring decisions in model-informed evidence and insights to accelerate timelines, enhance regulatory confidence, and strengthen investment decisions.